Your session is about to expire
← Back to Search
Prediction Models for Lung Cancer Screening (PASI Trial)
N/A
Waitlist Available
Led By Nichole T Tanner, MD MS BS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Meeting USPSTF eligibility criteria for LCS, as currently encoded in the background logic of LCS clinical reminders maintained by the VA National Center for Lung Cancer Screening (i.e., age 50-80 years; smoked 20 pack-years; current smoking or quit <15 years ago)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 years
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to show that using prediction models to identify high-risk individuals for lung cancer screening can help improve efficiency and reduce disparities. The goal is to demonstrate that this approach can be implemented successfully and increase
Who is the study for?
This trial is for individuals eligible for lung cancer screening, particularly focusing on Veterans who are at high risk but have low screening rates. It aims to improve early detection in this group, with an emphasis on reducing disparities and increasing uptake among Black Veterans.
What is being tested?
The study tests whether using prediction models alongside population management tools can increase the efficiency of lung cancer screenings (LCS) and encourage higher participation rates among Veterans.
What are the potential side effects?
Since this trial focuses on implementing a new approach to screening rather than testing a medical treatment or drug, there are no direct side effects associated with traditional clinical interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 50-80 years old, have a 20 pack-year smoking history, and either currently smoke or quit less than 15 years ago.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
LDCT receipt
Secondary study objectives
Black Veteran Uptake
Complications from invasive procedures
High-benefit Veteran Uptake
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: PCP facing tools plus LCS population management dashboardExperimental Treatment2 Interventions
both interventions activated
Group II: PCP facing toolsExperimental Treatment2 Interventions
Suite of PCP facing tools activated
Group III: LCS team population management toolsExperimental Treatment2 Interventions
site-specific dashboard and proactive outreach toolkit
Group IV: Usual CareActive Control1 Intervention
Usual care
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,668 Previous Clinical Trials
3,742,346 Total Patients Enrolled
Nichole T Tanner, MD MS BSPrincipal InvestigatorRalph H. Johnson VA Medical Center, Charleston, SC